Characterization of a hypertriglyceridemic transgenic miniature pig model expressing human apolipoprotein CIII

FEBS Journal

Volumn 279, Issue 1, 2012, Pages 91-99

  Wei, Jingyuan ^a,b   Ouyang, Hongsheng ^a   Wang, Yuhui ^c   Pang, Daxin ^a   Cong, Nathan X ^c   Wang, Tiedong ^a   Leng, Bingfeng ^a   Li, Dong ^a   Li, Xiaoping ^a   Wu, Rong ^a   Ding, Yu ^a   Gao, Fei ^a   Deng, Yanhong ^a   Liu, Bo ^a   Li, Ziyi ^a   Lai, Liangxue ^a   Feng, Haihua ^a   Liu, George ^c   Deng, Xuming ^a  

^a JILIN UNIVERSITY   (China)

^b Liaoning Province Academy of Analytic Science   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

apolipoprotein CIII; hypertriglyceridemia; miniature pig; model; transgenic

Indexed keywords

APOLIPOPROTEIN C3; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS TRANSPLANTATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; FAST PROTEIN LIQUID CHROMATOGRAPHY; GENE; HUMAN; HYPERTRIGLYCERIDEMIA; IMMUNOFLUORESCENCE TEST; LIPID ANALYSIS; LIPID METABOLISM; MALE; MINIPIG; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOMATIC CELL; TRANSGENIC PIG; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; APOLIPOPROTEIN C-III; BLOTTING, WESTERN; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; HYPERTRIGLYCERIDEMIA; IMMUNOENZYME TECHNIQUES; INTESTINES; LIPIDS; LIPOPROTEINS; LIVER; MALE; MICE; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUS SCROFA; TRIGLYCERIDES;

ANIMALIA; MUS; MUS MUSCULUS; SUIDAE;

EID: 83655161317     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2011.08401.x     Document Type: Article

References (30)

1. Jong MC, Hofker MH, &, Havekes LM, (1999) Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler Thromb Vasc Biol 19, 472-484. (Pubitemid 29135144)
2. Narayanaswami V, &, Ryan RO, (2000) Molecular basis of exchangeable apolipoprotein function. Biochim Biophys Acta 1483, 15-36.
3. Clavey V, Lestavel-Delattre S, Copin C, Bard JM, &, Fruchart JC, (1995) Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E. Arterioscler Thromb Vasc Biol 15, 963-971.
4. Zannis VI, Kan HY, Kritis A, Zanni EE, &, Kardassis D, (2001) Transcriptional regulatory mechanisms of the human apolipoprotein genes in vitro and in vivo. Curr Opin Lipidol 12, 181-207. (Pubitemid 32242926)
5. Kan H-Y, Georgopoulos S, &, Zannis V, (2000) A hormone response element in the human apolipoprotein CIII (apoCIII) enhancer is essential for intestinal expression of the apoAI and apoCIII genes and contributes to the hepatic expression of the two linked genes in transgenic mice. J Biol Chem 275, 30423-30431.
6. Georgopoulos S, Kan HY, Reardon-Alulis C, &, Zannis V, (2000) The SP1 sites of the human apoCIII enhancer are essential for the expression of the apoCIII gene and contribute to the hepatic and intestinal expression of the apoAI gene in transgenic mice. Nucleic Acids Res 28, 4919-4929. (Pubitemid 32014262)
7. Walsh A, Azrolan N, Wang K, Marcigliano A, O'Connell A, &, Breslow JL, (1993) Intestinal expression of the human apoAI gene in transgenic mice is controlled by a DNA region 3′ to the gene in the promoter of the adjacent convergently transcribed apoCIII gene. J Lipid Res 34, 617-623. (Pubitemid 23118762)
8. Li Y-J, Wei Y-S, &, Fu X-H, (2008) The apolipoprotein CIII enhancer regulates both extensive histone modification and intergenic transcription of human apolipoprotein AI/CIII/AIV genes but not apolipoprotein AV. J Biol Chem 283, 28436-28444.
9. Jeppesen J, Hein HO, Suadicani P, &, Gyntelberg F, (1998) Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation 97, 1029-1036.
10. Miller M, Seidler A, Moalemi A, &, Pearson TA, (1998) Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study. J Am Coll Cardiol 31, 1252-1257. (Pubitemid 128713120)
11. Assmann G, Schulte H, &, von Eckardstein A, (1996) Hypertriglyceridemia and elevated levels of lipoprotein(a) are risk factors for major coronary events in middle-aged men. Am J Cardiol 77, 1179-1184. (Pubitemid 26186958)
12. Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM, &, Hennekens CH, (1996) A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 276, 882-888. (Pubitemid 26301607)
13. Cohn JS, Patterson BW, Uffelman KD, Davignon J, &, Steiner G, (2004) Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity. J Clin Endocrinol Metab 89, 3949-3955. (Pubitemid 39071498)
14. Pollin TI, Damcott CM, Shen H, Ott SH, Shelton J, Horenstein RB, Post W, McLenithan JC, Bielak LF, Peyser PA, et al. (2008) A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Science 322, 1702-1705.
15. Ito Y, Azrolan N, O'Connell A, Walsh A, &, Breslow JL, (1990) Hypertriglyceridemia as a result of human apoCIII gene expression in transgenic mice. Science 249, 790-793.
16. Jokinen MP, Clarkson TB, &, Prichard RW, (1985) Animal models in atherosclerosis research. Exp Mol Pathol 42, 1-28. (Pubitemid 15170629)
17. Mahley RW, Weisgraber KH, Innerarity T, Brewer HB Jr, &, Assmann G, (1975) Swine lipoproteins and atherosclerosis. Changes in the plasma lipoproteins and apoproteins induced by cholesterol feeding. Biochemistry 14, 2817-2823.
18. Douglas WR, (1972) Of pigs and men and research: a review of applications and analogies of the pig, Sus scrofa, in human medical research. Space Life Sci 3, 226-234.
19. Lee KT, (1986) Swine as animal models in cardiovascular research. In Swine in Biomedical Research (, Tumbleson ME, ed.), pp. 1481-1496. Plenum Press, NY.
20. White FC, &, Bloor CM, (1986) The pig as a model for myocardial ischemia. In Swine in Biomedical Research (, Tumbleson ME, ed.), pp. 481-490. Plenum Press, NY.
21. Longhurst JC, &, Symons JD, (1993) Function and development of coronary collateral vessels. In Collateral Circulation (, Schaper W, &, Schaper J, eds), pp. 195-214. Kluwer Academic Publishers, Boston.
22. Van der Ham RLM, Dehnavi RA, Berbée JFP, Putter H, de Roos A, Romijn JA, Rensen PCN, &, Tamsma JT, (2009) Plasma apolipoprotein CI and CIII levels are associated with increased plasma triglyceride levels and decreased fat mass in men with the metabolic syndrome. Diabetes Care 32, 184-186.
23. Prather RS, Sutovsky P, &, Green JA, (2004) Nuclear remodeling and reprogramming in transgenic pig production. Exp Biol Med 229, 1120-1126. (Pubitemid 39602254)
24. Ding Y, Wang Y, Zhu H, Fan J, Yu L, Liu G, &, Liu E, (2011) Hypertriglyceridemia and delayed clearance of fat load in transgenic rabbits expressing human apolipoprotein CIII. Transgenic Res 20, 867-875.
25. Aalto-Setälä K, Fisher E, Chen X, Chajek-Shaul T, Hayek T, Zechner R, Walsh A, Ramakrishnan R, Ginsberg HN, &, Breslow JL, (1992) Mechanism of hypertriglyceridemia in human apolipoprotein (Apo) CIII transgenic mice diminished very low density lipoprotein fractional catabolic rate associated with increased Apo CIII and reduced Apo E on the particles. J Clin Invest 90, 1889-1900.
26. Turk JR, Henderson KK, Vanvickle GD, Watkins J, &, Laughlin MH, (2005) Arterial endothelial function in a porcine model of early stage atherosclerotic vascular disease. Int J Exp Pathol 86, 335-345. (Pubitemid 41413628)
27. Bunker AK, &, Laughlin MH, (2010) Influence of exercise and perivascular adipose tissue on coronary artery vasomotor function in a familial hypercholesterolemic porcine atherosclerosis model. J Appl Physiol 108, 490-497.
28. Lai L, &, Prather RS, (2003) Production of cloned pigs by using somatic cells as donors. Cloning Stem Cells 5, 233-241. (Pubitemid 38031849)
29. Lai L, Kolber-Simonds D, Park KW, Cheong HT, Greenstein JL, Im GS, Samuel M, Bonk A, Rieke A, Day BN, et al. (2002) Production of α-1,3- galactosyltransferase knockout pigs by nuclear transfer cloning. Science 95, 1089-1092. (Pubitemid 34132242)
30. Fan J, Unoki H, Kojima N, Sun H, Shimoyamada H, Deng H, Okazaki M, Shikama H, Yamada N, &, Watanabe T, (2001) Overexpression of lipoprotein lipase in transgenic rabbits inhibits diet-induced hypercholesterolemia and atherosclerosis. J Biol Chem 276, 40071-40079.